Padryk Merkl

Dr. Padryk Merkl is a postdoctoral researcher affiliated with the Institute of Pharmaceutical Sciences (IPW) at ETH Zürich, specifically within the Professorship for Drug Formulation and Delivery. His work focuses on developing high-throughput technologies, particularly in the realm of nanotechnology and drug delivery systems. Key research areas include photothermal microneedles, antibiofilm coatings, and plasmonic nanoparticle applications in diagnostics and therapy.

His research interests span pharmaceutical sciences, nanomaterials, and biomedical engineering. Notably, he explores laser-activated drug amorphization and photocatalytic materials for antibacterial applications. Recent studies highlight innovations in colorimetric sensors, SARS-CoV-2 antiviral coatings, and immune mechanisms in pneumonia.

Dr. Merkl’s publications reflect a strong emphasis on translating nanotechnology into practical solutions for healthcare challenges, such as biofilm eradication and targeted drug delivery. His work bridges fundamental material science with clinical applications, contributing to advancements in both drug formulation and diagnostic tools.